MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-30-2026
Merit Medical Systems Total Assets 2011-2026 | MMSI
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Merit Medical Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.69 B | 2.42 B | 2.33 B | 1.66 B | 1.65 B | 1.66 B | 1.76 B | 1.62 B | 1.11 B | 943 M | 779 M | 747 M | 728 M | 705 M | 447 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.69 B | 447 M | 1.42 B |
Quarterly Total Assets Merit Medical Systems
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.72 B | 2.69 B | 2.59 B | 2.47 B | 2.42 B | 2.38 B | 2.37 B | 2.33 B | 2.33 B | 1.81 B | 1.84 B | 1.68 B | 1.66 B | 1.63 B | - | 1.63 B | 1.65 B | 1.64 B | 1.64 B | 1.65 B | 1.66 B | 1.66 B | 1.66 B | 1.66 B | 1.76 B | 1.76 B | 1.76 B | 1.76 B | 1.62 B | 1.62 B | 1.62 B | 1.62 B | 1.11 B | 1.11 B | 1.11 B | 1.11 B | 943 M | 943 M | 943 M | 943 M | 779 M | 779 M | 779 M | 779 M | 747 M | 747 M | 747 M | 747 M | 728 M | 728 M | 728 M | 728 M | 705 M | 705 M | 705 M | 705 M | 447 M | 447 M | 447 M | 447 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.72 B | 447 M | 1.38 B |
Total Assets of other stocks in the Medical instruments industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
12.4 B | $ 59.78 | -0.99 % | $ 11.9 B |  USA |
 |
Atrion Corporation
ATRI
|
261 K | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
825 M | - | - | $ 1.75 B | USA |
 |
iRhythm Technologies
IRTC
|
1.02 B | $ 114.31 | 0.13 % | $ 3.66 B | USA |
 |
ICU Medical
ICUI
|
4.05 B | $ 119.39 | -2.93 % | $ 2.94 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
10.9 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
20.5 B | $ 421.75 | -1.47 % | $ 151 B | USA |
 |
Repro Med Systems
KRMD
|
28.2 M | $ 3.93 | -1.26 % | $ 182 M | USA |
 |
Alcon
ALC
|
31.6 B | $ 63.78 | -0.34 % | $ 40.4 B |  Schweiz |
 |
LeMaitre Vascular
LMAT
|
616 M | $ 97.38 | -2.13 % | $ 2.2 B | USA |
 |
Masimo Corporation
MASI
|
2.63 B | $ 178.49 | 0.08 % | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
213 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.07 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
192 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
4.67 B | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
20.1 M | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
5.68 B | $ 23.4 | -1.89 % | $ 3.93 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
4.46 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
18.7 M | $ 6.04 | -6.07 % | $ 51.2 K | USA |
 |
Haemonetics Corporation
HAE
|
2.45 B | $ 56.73 | -0.68 % | $ 2.86 B | USA |
 |
Isoray
ISR
|
267 M | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
940 M | $ 143.49 | 0.93 % | $ 6.95 B | USA |
 |
STAAR Surgical Company
STAA
|
452 M | $ 32.41 | 1.25 % | $ 1.61 B | USA |
 |
STERIS plc
STE
|
10.1 B | $ 211.83 | -1.92 % | $ 20.9 B | USA |
 |
Teleflex Incorporated
TFX
|
6.95 B | $ 130.52 | 0.18 % | $ 5.82 B | USA |
 |
InfuSystem Holdings
INFU
|
101 M | $ 8.65 | 0.46 % | $ 179 M | USA |
 |
Microbot Medical
MBOT
|
81.5 M | $ 1.88 | 1.35 % | $ 86.1 M |  Israel |
 |
Milestone Scientific
MLSS
|
7.81 M | $ 0.33 | -2.77 % | $ 27.1 M | USA |
 |
Utah Medical Products
UTMD
|
123 M | $ 63.27 | -0.68 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
4.27 B | $ 303.95 | 1.25 % | $ 22 B | USA |
 |
Pulse Biosciences
PLSE
|
94.5 M | $ 24.33 | -10.22 % | $ 1.64 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
5.43 B | $ 9.99 | -3.99 % | $ 1.99 B | USA |
 |
Retractable Technologies
RVP
|
143 M | $ 0.65 | -5.8 % | $ 19.5 M | USA |
 |
Pro-Dex
PDEX
|
61.2 M | $ 59.75 | 1.88 % | $ 196 M | USA |
 |
Predictive Oncology
POAI
|
52.9 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
406 M | $ 20.35 | -3.4 % | $ 972 M | USA |
 |
Stereotaxis
STXS
|
52.3 M | $ 1.89 | -3.08 % | $ 172 M | USA |
 |
Baxter International
BAX
|
20.1 B | $ 17.34 | -2.47 % | $ 8.9 B | USA |
 |
ResMed
RMD
|
5.1 B | $ 202.44 | -0.01 % | $ 29.6 B | USA |
 |
AtriCure
ATRC
|
654 M | $ 28.16 | 0.04 % | $ 1.34 B | USA |
 |
Harvard Bioscience
HBIO
|
80.1 M | $ 5.37 | -2.72 % | $ 238 M | USA |
 |
NeuroMetrix
NURO
|
15.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
280 M | $ 10.79 | -2.18 % | $ 441 M | USA |
 |
Becton, Dickinson and Company
BDX
|
55.3 B | $ 143.35 | -0.77 % | $ 41.2 B | USA |
 |
Nephros
NEPH
|
13.6 M | $ 3.23 | -1.1 % | $ 34.3 M | USA |
 |
OraSure Technologies
OSUR
|
403 M | $ 3.07 | 3.9 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
2.95 B | $ 103.63 | 0.24 % | $ 5.83 M | USA |